Core Viewpoint - The company, Yidu Tech (02158), has been actively repurchasing its shares, signaling confidence in its value and positively impacting market sentiment [1] Group 1: Share Buyback Activity - On February 9, Yidu Tech announced a share buyback of 910,000 shares at approximately HKD 5.77 per share, totaling over HKD 5 million [1] - This marks the 11th consecutive trading day of intensive buybacks, with a cumulative repurchase amount of approximately HKD 58 million [1] - The stock price of Yidu Tech rose by 3.39% on the same day, closing at HKD 5.79, reflecting a positive market response to the buyback [1] Group 2: Analyst Ratings and Market Position - Citigroup maintained a "Buy" rating for Yidu Tech and raised its target price to HKD 11 [1] - The company has established a strong presence in national-level AI medical application pilot projects in regions like Beijing and Henan, enhancing operational efficiency in medical institutions [1] - Yidu Tech's products, such as the Doctor Copilot, and its consumer-facing "Yidu Qianyu" demonstrate solid technical capabilities, ranking alongside leading products in accuracy and traceability of medical evidence [1]
医渡科技(02158)连续11个交易日回购 2月9日回购超500万港元